| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |